Biotechnology/Chemical/Pharmaceutical/Customer Partnership

Tuesday September 9, 2009

United States Patent and Trademark Office Alexandria,
Virginia Randolph Conference Center
401 Dulany Street, Alexandria, VA

The most recent quarterly meeting for the Biotechnology and Chemical Pharmaceutical Customer Partnership was held on June 3, 2008 at the U.S. Patent and Trademark Office. The Biotechnology and Chemical Pharmaceutical Customer Partnership is designed and developed to be a forum to share ideas, experiences, and insights between individual users and the USPTO. The USPTO does not intend to use these customer partnership groups to arrive at any consensus. Invitations to participate will indicate that individual opinions are sought, rather than a group consensus and that the meetings are intended to be informal in nature and have varying participants. These customer partnership groups are formed with full recognition of the USPTO's responsibility under the Federal Advisory Committee Act (FACA), and that these customer partnership groups are not established as FACA compliant committees.

We value our customers in obtaining feedback from individual participants is important in our efforts to continuously improve the quality of our products and services. Your willing participation is helpful in providing us with insights and experiences in this informal process to assist us..

The next meeting of the U.S. Patent and Trademark Office Biotechnology and Chemical Pharmaceutical Customer Partnership is scheduled for Tuesday, September 9, 2008 from 9:00 am to 4:30 pm atRandolph Conference Center, 401 Dulany Street, Alexandria, Virginia..

For information of future meetings and presentations, please go to .

The meeting is being webcast. You can join the meeting on line. Please go to the below link and sign in as guest the day of the meeting.

Please contact Cecilia Tsang at 571-272-0562, or by fax at 571-273-0562, or email to decline or confirm your attendance by September 4, 2008.

Webcast Link

Time Morning Session Presenter
Greetings and Overview
John LeGuyader, George Elliott,
Irem Yucel, Directors,
Technology Center 1600
Broadest Reasonable
Interpretation Standard
Janet Gongola
Associate Solicitor
0ffice of the Solicitor
Double Patenting
Tony Caputa
Office of Patent Quality Assurance
PPAC Outreach Efforts
Andrew Faile
Assistant Deputy Commissioner for Patents
Time Afternoon Session Presenter
1:15-2:00 Trilateral Examiner Exchange's
View of Microarrays
B.J. Forman, Art Unit 1634
2:00-2:15 Break  
Issues in Patenting Proteins
Jon Weber, SPE, Art Unit 1657
Incorporation by Reference
Jean Witz, QAS, TC1600
3:45-4:00 Closing Remarks/Discussion John LeGuyader, George Elliott,
Irem Yucel, Directors,
Technology Center 1600